LivaNova PLC
—- Market cap
- —
- Debt
- +$376.66M
- Cash
- −$635.55M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: LIVN stock price vs F: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at F's multiple
Needs F P/S.
Implied fair value · at LIVN's multiple
Needs Revenue / share, LIVN P/S.
Close Dec 31, 2025
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
LivaNova PLC · implied price per share
Bear
$33.79
Base
$38.91
Bull
$45.57
Ford Motor Co · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Medtronic plc
LIVN vs MDT
ABBOTT LABORATORIES
LIVN vs ABT
BAXTER INTERNATIONAL INC
LIVN vs BAX
BOSTON SCIENTIFIC CORP
LIVN vs BSX
General Motors Co
LIVN vs GM
Tesla, Inc.
LIVN vs TSLA
Stellantis N.V.
LIVN vs STLA
TOYOTA MOTOR CORP/
LIVN vs TM
HONDA MOTOR CO LTD
LIVN vs HMC
Lucid Group, Inc.
LIVN vs LCID
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe LIVN can sustain its 10.7% revenue growth while maintaining 67.7% gross margin and 14.4% operating margin, then hold rather than sell aggressively because the operational profile is better than F's despite the very large F-multiple discount signal.
LIVN trades at 3.2x P/S versus F at 0.3x P/S, while the model-implied price for LIVN is $7.42 versus the current $80.14, implying a -90.7% downside on this F-multiple basis. The gap is driven by the fact that LIVN has far superior gross and operating margins than F, but the valuation spread is still extreme.
Supporting Metrics